Ningbo Tianyi Medical Appliance's subsidiary obtains a drug registration certificate.

Ningbo Tianyi Medical Appliance (301097.SZ) announced that its subsidiary Ningbo Tianyi Pharmaceutical Technology Co., Ltd. (referred to as "Tianyi Pharmaceuticals") recently received a Drug Registration Certificate issued by the National Medical Products Administration. The approved drug is "Sodium Bicarbonate Hemodiafiltration Replacement Solution," which is used in Continuous Renal Replacement Therapy (CRRT) to replenish replacement fluids and correct the imbalance of the patient's internal environment. Its core component, sodium bicarbonate, as a base, can be used to correct metabolic acidosis, while electrolytes such as sodium chloride, potassium chloride, calcium chloride, and magnesium chloride help maintain stable and balanced electrolyte concentrations in the patient's blood. This product provides the necessary buffer and electrolyte supplementation for CRRT treatment, supports stable blood purification therapy, does not require additional configuration, can be used directly on the machine, simplifies clinical operations, and is especially suitable for critically ill patients requiring long-term, continuous renal replacement therapy.